FORM 10-K
FORM 10-K
Rest EZ, Inc. filed its annual report for the fiscal year ended March 31, 2026, reporting no significant financial figures or events. The company is a non-accelerated filer and a smaller reporting company, with a market value of $250,000 and 60,000,000 shares of common stock outstanding as of March 31, 2026. The report does not provide any information on the company’s financial performance, revenue, or net income, and does not indicate any significant developments or events during the fiscal year.
Summary and Analysis of Key Points
Overview of the Company’s Financial Performance
Rest EZ, Inc. is a company that produces and distributes a sleep aid supplement called the Rest EZ Sleep Aid Supplement. The company was incorporated in 2016 and is currently in the full production and distribution stage.
The company’s financial performance has been mixed. During the year ended March 31, 2026, the company generated $0 in total sales, with a cost of sales of $0. Selling, general, and administrative costs were $14,700, resulting in a net loss of $14,700. This represents a decline from the prior year, where the company had $0 in sales and a net loss of $7,900.
The company’s cash flow has also been challenging, with $3,556 used in operating activities in the year ended March 31, 2026, compared to $44,705 used in the prior year. The company did not have any financing activities in the most recent year, whereas it received $45,005 in financing in the prior year.
Revenue and Profit Trends
The company’s revenue and profit trends have been flat, with no sales generated in the past two fiscal years. This suggests that the company has struggled to gain traction in the market and generate meaningful revenue from its sleep aid supplement.
The company’s net losses have increased from $7,900 in the year ended March 31, 2025, to $14,700 in the year ended March 31, 2026, indicating that the company’s expenses are outpacing its revenue. This is a concerning trend that the company will need to address to achieve profitability.
Strengths and Weaknesses
One of the company’s strengths is its product, which is a liquid gel capsule that the company believes is superior to competitors’ products due to its soft gel form, which avoids substantial product breakdown before digestion. However, the company does not have any intellectual property protection for its product, which could make it vulnerable to competition.
Another weakness is the company’s reliance on its sole executive officer and director, Mr. Carson. The company’s success is dependent on his judgment, skill, and knowledge, and there is no assurance that a suitable replacement could be found if he were to retire, resign, or pass away.
The company’s lack of diversification in its business plan is also a weakness, as it is solely focused on the sleep aid supplement market, which is highly competitive and may affect the company’s ability to maintain profitable operations in the future.
Outlook for the Future
The company’s outlook for the future is uncertain. The COVID-19 pandemic has not had a material impact on the company so far, but the company acknowledges that the pandemic may have an impact on its ability to evaluate and acquire an operating entity through a reverse merger or otherwise.
The company plans to build out its reputation further and expand to additional wholesalers, retail chain stores, and online sales over the next twelve months. However, the company’s ability to execute on this plan is dependent on its ability to raise additional capital, as it has minimal revenue and substantial doubt about its ability to continue as a going concern.
Overall, Rest EZ, Inc. faces significant challenges in its efforts to establish a profitable business in the highly competitive sleep aid supplement market. The company’s financial performance has been weak, and it will need to address its reliance on a single executive, lack of diversification, and need for additional capital to improve its outlook for the future.